NXTC - NextCure  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NXTC is currently covered by 3 analysts with an average price target of $11.37. This is a potential upside of $6.36 (126.95%) from yesterday's end of day stock price of $5.01.

NextCure 's activity chart (see below) currently has 47 price targets and 49 ratings on display. The stock rating distribution of NXTC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.03% with an average time for these price targets to be met of 174.5 days.

Highest price target for NXTC is $15, Lowest price target is $3, average price target is $7.33.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 15-Jul-2025. First documented stock forecast 03-Jun-2019.

Currently out of the existing stock ratings of NXTC, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$8.83 (143.11%)

$6

16 days ago
(15-Jul-2025)

4/15 (26.67%)

$10.24 (215.13%)

291

Buy

$3

$-3.17 (-51.38%)

$3

30 days ago
(01-Jul-2025)

4/5 (80%)

$2.56 (581.82%)

127

Buy

$4

$-2.17 (-35.17%)

$4

11 months 29 days ago
(02-Aug-2024)

6/7 (85.71%)

$2.4 (150.00%)

659

Hold

$16

2 years 8 months 27 days ago
(04-Nov-2022)

0/3 (0%)

$11.08 (225.20%)

Buy

$15

$8.83 (143.11%)

$19

2 years 11 months 8 days ago
(23-Aug-2022)

1/4 (25%)

$10.56 (237.84%)

185

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NXTC (NextCure ) average time for price targets to be met?

On average it took 174.5 days on average for the stock forecasts to be realized with a an average price target met ratio 45.03

Which analyst has the current highest performing score on NXTC (NextCure ) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on NXTC (NextCure ) with a proven track record?

CHAD MESSER

Which analyst has the most public recommendations on NXTC (NextCure )?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on NXTC

Which analyst is the currently most bullish on NXTC (NextCure )?

Chad Messer with highest potential upside - $12.92

Which analyst is the currently most reserved on NXTC (NextCure )?

Emily Bodnar with lowest potential downside - -$3.17

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?